TEXT SIZE: larger text smaller text

Home > Our Doctors > Find a Doctor

Select Physicians to compare
Photo of Erik Zeger

Erik L Zeger , MD

Request an Appointment

Need help deciding?
Contact 1.866.CALL.MLH or
484.580.1000 for assistance.

Medical Group:

Main Line Oncology/Hematology
Specialties Accepting New Patients
  Board Certified in 2005
Internal Medicine
  Board Certified in 2002

Age: 43      Gender: M

Medical School:
Medical College of Pennsylvania- Hahnemann School of Medicine

University of North Carolina

University of North Carolina

Primary Affiliation:  Lankenau Medical Center

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Main Line Oncology/Hematology   (view other physicians at this practice)

Office Information

Lankenau Cancer Center
100 East Lancaster Avenue
Wynnewood, PA  19096
TEL: 610.645.2494 FAX: 610.645.4456
View Map | Get Directions

Hours: Weekdays

Erik L Zeger

Main Line Oncology/Hematology
100 East Lancaster Avenue
Wynnewood, PA  19096
TEL: 610.645.2494 FAX: 610.645.4456
View Map | Get Directions

Access Information:
Public Transportation, Handicap Access


Recent Clinical Studies Published

Zeger EL, Kyle R, Osborne K, Li W.2004.Case Presentations in Multiple Myeloma, Metastatic Breast Cancer and Angiogenesis Inhibition. Big Sky Oncology Conference. Big Sky, Montana.

DeNittis AS, Thompson A, Marks G, Valsdottir EB, Zeger EL, Marks J. Identifying Rectal Shift Using Cone Beam Computed Tomography during Preoperative Intensity Modulated Radiation Therapy. Presented at ASTRO, Boston, MA. Spet 2008.

Valsdottir EB, Newman DA, Yarandi SS, Marks JH, Marks G, Zeger EL, DeNittis AS. Number of Lymph Nodes Cannot be Used as a Surrogate for Adequacy of Resection after Neoadjuvant Therapy for Rectal Cancer. Presented ASCRS, 2008.

Orlowski R,Zeger EL. Targeting the Proteasome as a Therapeutic Strategy against Haematological Malignancies. Expert Opinion Investig. Drugs. 2006 Feb;15(2):117-130.

Collichio F, Ollila D, Huck K, Mullen N, Shearer H, Turner E, Kelly H, Zeger EL, Socinski M. A Phase II Trial of Weekly 1-Hour Paclitaxel in Stage IV Melanoma. ASCO Annual meeting proceedings 2005.

Current Memberships and Activities

American Society of Clinical Oncology

American Society of Hematology

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.

Compare Physicians

Connect with

New Appointments


Copyright 2011 Main Line Health

Printed from: www.mainlinehealth.org/phy/Page.asp?PageID=PHY001303

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.